Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients

BMC Neurol. 2005 Jun 20:5:11. doi: 10.1186/1471-2377-5-11.

Abstract

Background: Fibroblast growth factor 20 (FGF20) is a neurotrophic factor preferentially expressed in the substantia nigra of rat brain and could be involved in dopaminergic neurons survival. Recently, a strong genetic association has been found between FGF20 gene and the risk of suffering from Parkinson's disease (PD). Our aim was to replicate this association in two independent populations.

Methods: Allelic, genotypic, and haplotype frequencies of four biallelic polymorphisms were assessed in 151 sporadic PD cases and 186 controls from Greece, and 144 sporadic PD patients and 135 controls from Finland.

Results: No association was found in any of the populations studied.

Conclusion: Taken together, these findings suggest that common genetic variants in FGF20 are not a risk factor for PD in, at least, some European populations.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Case-Control Studies
  • Fibroblast Growth Factors / genetics*
  • Finland / epidemiology
  • Gene Frequency
  • Genotype
  • Greece / epidemiology
  • Humans
  • Linkage Disequilibrium
  • Middle Aged
  • Parkinson Disease / epidemiology
  • Parkinson Disease / genetics*
  • Polymorphism, Genetic*
  • Prospective Studies

Substances

  • FGF20 protein, human
  • Fibroblast Growth Factors